Correlation Between Rakovina Therapeutics and Canadian Net

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rakovina Therapeutics and Canadian Net at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rakovina Therapeutics and Canadian Net into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rakovina Therapeutics and Canadian Net Real, you can compare the effects of market volatilities on Rakovina Therapeutics and Canadian Net and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rakovina Therapeutics with a short position of Canadian Net. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rakovina Therapeutics and Canadian Net.

Diversification Opportunities for Rakovina Therapeutics and Canadian Net

0.73
  Correlation Coefficient

Poor diversification

The 3 months correlation between Rakovina and Canadian is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Rakovina Therapeutics and Canadian Net Real in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Canadian Net Real and Rakovina Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rakovina Therapeutics are associated (or correlated) with Canadian Net. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Canadian Net Real has no effect on the direction of Rakovina Therapeutics i.e., Rakovina Therapeutics and Canadian Net go up and down completely randomly.

Pair Corralation between Rakovina Therapeutics and Canadian Net

Assuming the 90 days horizon Rakovina Therapeutics is expected to generate 8.5 times more return on investment than Canadian Net. However, Rakovina Therapeutics is 8.5 times more volatile than Canadian Net Real. It trades about 0.1 of its potential returns per unit of risk. Canadian Net Real is currently generating about 0.12 per unit of risk. If you would invest  50.00  in Rakovina Therapeutics on April 22, 2025 and sell it today you would earn a total of  18.00  from holding Rakovina Therapeutics or generate 36.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Rakovina Therapeutics  vs.  Canadian Net Real

 Performance 
       Timeline  
Rakovina Therapeutics 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Rakovina Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Rakovina Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Canadian Net Real 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Canadian Net Real are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat abnormal basic indicators, Canadian Net may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Rakovina Therapeutics and Canadian Net Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rakovina Therapeutics and Canadian Net

The main advantage of trading using opposite Rakovina Therapeutics and Canadian Net positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rakovina Therapeutics position performs unexpectedly, Canadian Net can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Canadian Net will offset losses from the drop in Canadian Net's long position.
The idea behind Rakovina Therapeutics and Canadian Net Real pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets